MedPath

The Study of Glycemic Index of GEN-DM modified formula

Phase 4
Completed
Conditions
This study would like to calculate glycemic index of Gen-DM MF by examination of blood glucose in healthy volunteers.
Glycemic Index (GI), Low glycemic Index formulation supplement, Gen-DM MF
Registration Number
TCTR20230922003
Lead Sponsor
Thai Otsuka Pharmaceutical Co., Ltd. 
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria

1.Able to obtain inform consent form patients or his/her legal representative
2.Patients of both sexes who are at least 18 years old
3.Body Mass Index is 18.5 - 24.9 kg/m2
4.Heathy volunteer
5.No Smoking, alcohol drinking, drugs and substance Abuse
6.Oral Glucose Tolerance Test lower than 140 mg/dL

Exclusion Criteria

1.Having family history or diagnosed with Diabetes Mellitus.
2.Taking insulin or glucose-lowering medication within 1 month previous joining this study.
3.Allergic to components of study formula .
4.Having history or diagnosed with Diabetes Mellitus, Hypertension, Cardiovascular disease, Chronic liver disease, chronic kidney disease, Thyroid disease, Maldigestion and Malabsorption.
5.Taking other study investigated product, medical food or vitamins within 7 days previous joining this study.
6.Not able to following the study protocol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glycemic index 0, 30, 60, 90 and 120 minutes Calculated by the ratio of AUC(blood glucose of GEN-DM MF) to AUC(blood glucose of glucose) and multiplied by 100
Secondary Outcome Measures
NameTimeMethod
blood glucose 0, 30, 60, 90 and 120 minutes Blood collection
© Copyright 2025. All Rights Reserved by MedPath